Maze Therapeutics begins Phase 2 trial for kidney disease drug By Investing.com - Feb 07, 2025 SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical ...

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- On Jan. 23, 2025, Decent Holding Inc. (Nasdaq: DXST) (the “Company”), an established wastewater treatment services provider in China, announced the ...

Tech stocks led the market on Wednesday as Netflix (NFLX) stock surged to a record, while President Donald Trump's boost to AI demand hopes outweighed fresh tariff worries. Meanwhile, the Dow ...

Nvidia (NASDAQ: NVDA) stock posted significant gains in Wednesday's trading following bullish artificial intelligence (AI) news. The company's share price closed out the day up 4.4% amid the ...

Shares of Grail, a medical technology company, jumped 20% Wednesday to lead Nasdaq 100 gainers. Grail spun off from Illumina last year, and is developing a number of early detection cancer ...

The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s Rich Ross is prepared for that rally to continue, shrugging off fears ...

Netflix (Nasdaq: NFLX) is one of the more notable gainers today. We hosted a live blog during their earnings yesterday, and it was full of enthusiasm. The headline is the company added nearly 19 ...

On the Nasdaq, 1,835 stocks rose and 2,571 fell as declining issues outnumbered advancers by a 1.4-to-1 ratio. The S&P 500 posted 39 new 52-week highs and 4 new lows while the Nasdaq Composite ...

Here’s a look at where markets stand as of 11:10 a.m. ETF: The Dow Jones leads the S&P 500 and Nasdaq Composite in today’s trading. What’s driving its outperformance? 3M (NYSE: MMM ...

JetBlue Airways Corporation (NASDAQ:JBLU) announced on Tuesday that it is the first U.S. airline to accept payments through the Venmo service. The airline company said it is aiming to make it ...